Trials / Conditions / Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase

Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase

11 registered clinical trials studyying Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	EVAluation of Erythrocytosis PRospEctive Cohort STudy NCT06785870	Cyrus Hsia	—
Active Not Recruiting	Elotuzumab for the Treatment of JAK2-Mutated Myelofibrosis NCT04517851	M.D. Anderson Cancer Center	Phase 2
Withdrawn	PAT-1251 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essent NCT04054245	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Azacitidine, Venetoclax, and Pevonedistat in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia NCT03862157	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Withdrawn	Durvalumab in Treating Patients With Primary, Post-Polycythemia Vera, or Post-Essential Thrombocythemia Myelof NCT02871323	Northwestern University	Phase 1
Terminated	Nivolumab in Treating Patients With Primary Myelofibrosis, Post-Essential Thrombocythemia Myelofibrosis, or Po NCT02421354	M.D. Anderson Cancer Center	Phase 2
Completed	LCL161 in Treating Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post-Essentia NCT02098161	M.D. Anderson Cancer Center	Phase 2
Completed	Ruxolitinib Phosphate and Azacytidine in Treating Patients With Myelofibrosis or Myelodysplastic Syndrome/Myel NCT01787487	M.D. Anderson Cancer Center	Phase 2
Terminated	Anti-TGF-beta Therapy in Patients With Myelofibrosis NCT01291784	John Mascarenhas	Phase 1
Unknown	LBH589 (Panobinostat) for the Treatment of Myelofibrosis NCT01298934	Ronald Hoffman	Phase 1 / Phase 2
Completed	Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treati NCT00397813	Fred Hutchinson Cancer Center	Phase 2